Market revenue in 2024 | USD 223.9 million |
Market revenue in 2030 | USD 508.1 million |
Growth rate | 14.8% (CAGR from 2025 to 2030) |
Largest segment | Drug discovery |
Fastest growing segment | Drug Validation |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chemical Analysis, Drug Discovery, Drug Validation |
Key market players worldwide | Dassault Systemes SE, Agilent Technologies Inc, PerkinElmer, ChemAxon, Bio-Rad Laboratories Inc, Schrodinger Inc Ordinary Shares, Molecular Discovery, ACD labs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemoinformatics market will help companies and investors design strategic landscapes.
Drug discovery was the largest segment with a revenue share of 50.78% in 2024. Horizon Databook has segmented the China chemoinformatics market based on chemical analysis, drug discovery, drug validation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China chemoinformatics market , including forecasts for subscribers. This country databook contains high-level insights into China chemoinformatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account